LMR Partners »

Rapport Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $410k 20k 20.48
2024-06-30 $1.2M 50k 23.26

More positions owned by LMR Partners

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Put Option (NVDA)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Microstrategy Cl A New (MSTR)
Advanced Micro Devices Put Option (AMD)
Capri Holdings SHS Call Option (CPRI)
Tesla Motors (TSLA)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Endeavor Group Hldgs Cl A Com (EDR)
Microsoft Corporation (MSFT)
Moderna (MRNA)
Albertsons Cos Common Stock Call Option (ACI)
Dish Network Corporation Note 3.375% 8/1 (Principal)

View all positions for LMR Partners

Top funds holding Rapport Therapeutics

Arch Venture Corp
Cormorant Asset Management
Capital Research and Management Company - Division 3
Johnson & Johnson
Sofinnova Ventures
T. Rowe Price Investment Management
Alliancebernstein
T. Rowe Price Associates
Perceptive Advisors
BlackRock
Citadel Advisors
Siren
Logos Global Management
Geode Capital Management
Woodline Partners

View all funds holding Rapport Therapeutics